---
title : Pulmonary Hypertension
notetype : feed
feed: show
date :  2022-06-13
---
See also [[Right Ventricle RV Failure]]
## Definition 
- Persistent increase of mean pulmonary artery pressure mPAP of >25mmHg with a pulmonary artery occlusion pressure <15mmHg [^1] 
- Right ventricle systolic pressure (RVSP) often reported on the Echo does NOT equal mPAP, nor PH. Often they are correlated but not always. 
- RVSP = sPAP (in theory, systolic) NOT mPAP
- However, clinically we use RVSP as a predictor of mPAP & PH. It's correlation coefficient is 0.70 (positive likelihood ratio 3.0(1.7-5.3), negative likelihood ratio 0.24 (0.14-0.39)) [^2] so pretty decent
- Important to keep in mind the whole clinical picture

### Grading
RVSP 30-50 mild
RVSP 50-70 moderate
RVSP >70 moderate

Resources 

Chapter 53 Millers 

## Symptoms 
- dyspnea
- chest pain
- fatigue
- syncope
- 6 minute walk test
![[Pasted image 20220321162321.png]] [^3]
![[Pasted image 20220321162337.png]] [^4]


## Causes
### **1) Type 1:** Pulmonary arterial hypertension
	- primary
	- familial
	- collagen vascular disease
	- drugs/toxins
	
### **2) Type 2:** Pulmonary venous hypertension (aka left heart disease)
	- Left side heart disease/failure
	- Extrinsic compression of pulmonary veins
	
### **3) Type 3:** Pulmonary hypertension related to lung disease OR hypoxemia
	- COPD
	- ILD
	- Sleep-disordered breathing, severe OSA
	- Chronic high altitude
### **4) Type 4:** Pulmonary hypertension caused by chronic thromboembolic disease (CTEPH)
	- Pulmonary embolus
	- Sickle cell
### **5) Type 5:** Pulmonary Hypertension from direct vasculature involvement / idiopathic
	- Sarcoidosis
	- Schistosomiasis 

![[Pasted image 20220321153827.png]]
Miller's Chapter 38, page 1113

## Provoking Factors
1) Hypoxia
2) Hypercarbia
3) Acidosis
4) Hypothermia
5) Sympathetic stimulation & catecholamine release (pain)
6) Increased pressure; positive pressure ventilation, high PEEP


## Management principles

*"Euboxemia"*

Involves preventing the provoking factors discussed above
	- Normoxia
	- Normacarbia
	- Normal pH
	- Normal temperature
	- Avoid pain, stimulations
	- Lung protective ventilation, avoid high pressures, avoid PPV when feasible

- Reduced RV afterload
- Maintain coronary blood flow, sinus rhythm 
- Maintain SVR (fixed PVR so decreases in SVR = large decreases in CO)

- Box 53.3

    ![[Pulmonary%20Hypertension%20c49a700645cd4100ab06a3f3a8ff08ca 20210718_223656.jpg]]





### Pre-operative assessment
NYHA class is predictive of survival in these patients [^4]
Characterize symptoms as above
#### Investigations
- Routine labs
- CXR
- ECG
- Echo
	- RA enlargement
	- reduced TAPSE
	- pericardial effusion
- PFTs
- Blood gas
- Right heart catheterization
- pro-BNP

#### Medication management
Continue CCB, digoxin, diuretics, prostaglandins, dildenafil
Bridge warfarin
### Intra-operative
Consider regional technique rather than GA. 

#### Monitoring
- 5 lead ECG
- standard CAS monitors (esp temperature)
- Arterial line
- TEE or PA catheter for guiding resusc
    - 
#### Medications
- Norepinephrine desirable for contractility
    - Vasopressin increases SVR without increasing PVR

##### Vasopressor choice [^4]
![](/assets/img/Pastedimage20220613195042.png)
### Post-operative

## References
[^1]: Miller's 8E Chapter 38, page 1111
[^2]: Janda S, Shahidi N, Gin K, Swiston J. Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart. 2011 Apr;97(8):612-22. doi: 10.1136/hrt.2010.212084. Epub 2011 Feb 25. Erratum in: Heart. 2011 Jul;97(13):1112. PMID: 21357375.
[^3]: McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006 Sep 26;114(13):1417-31. doi: 10.1161/CIRCULATIONAHA.104.503540. PMID: 17000921.
[^4]: Sarkar MS, Desai PM. Pulmonary hypertension and cardiac anesthesia: Anesthesiologist's perspective. _Ann Card Anaesth_. 2018;21(2):116-122. doi:10.4103/aca.ACA_123_17